Global Firms Can Now Buy A Controlling Stake In Indian Companies, But The Debate Is Not Over
This article was originally published in PharmAsia News
Executive Summary
A truce between government departments was reached on the issue of foreign direct investments in the pharmaceutical industry. In the new setting, the “non-compete” clause will be removed lending flexibility to the seller to start up a competing enterprise.